|
TMEM57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68790004195785E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.00719999995835E-06 |
| Normal-vs-Stage2 |
5.278500E-03 |
| Normal-vs-Stage3 |
6.6613048410602E-11 |
| Normal-vs-Stage4 |
1.09690001526275E-09 |
| Stage1-vs-Stage2 |
2.697600E-01 |
| Stage1-vs-Stage3 |
1.955120E-03 |
| Stage1-vs-Stage4 |
2.816900E-03 |
| Stage2-vs-Stage3 |
2.524100E-03 |
| Stage2-vs-Stage4 |
2.641800E-03 |
| Stage3-vs-Stage4 |
5.434200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.58389992630259E-11 |
| Normal-vs-AfricanAmerican |
5.920600E-03 |
| Normal-vs-Asian |
2.14579999999742E-05 |
| Caucasian-vs-AfricanAmerican |
4.647200E-01 |
| Caucasian-vs-Asian |
6.469800E-02 |
| AfricanAmerican-vs-Asian |
7.688800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09370000003872E-06 |
| Normal-vs-Female |
3.24750004665475E-09 |
| Male-vs-Female |
1.775360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.60409999996991E-06 |
| Normal-vs-Age(41-60Yrs) |
3.17079995593161E-09 |
| Normal-vs-Age(61-80Yrs) |
2.36920000284968E-08 |
| Normal-vs-Age(81-100Yrs) |
2.603200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.166400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.866000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.235400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.318000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.851800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.637600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.31239974022446E-10 |
| Classical-VS-Follicular |
1.380520E-03 |
| Classical-VS-Other |
8.587600E-01 |
| Classical-VS-Normal |
7.60029994495426E-09 |
| Tall-VS-Follicular |
2.06401562508063E-12 |
| Tall-VS-Other |
3.955100E-03 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.384600E-01 |
| Follicular-VS-Normal |
2.020200E-02 |
| Other-VS-Normal |
8.076000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.27769999997063E-06 |
| Normal-vs-N1 |
3.96616073317091E-12 |
| N0-vs-N1 |
5.65849999999424E-05 |
|
|
